Pitcairn Co. boosted its stake in VCA Inc. (NASDAQ:WOOF) by 104.4% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 13,532 shares of the company’s stock after buying an additional 6,911 shares during the period. Pitcairn Co.’s holdings in VCA were worth $915,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in WOOF. Norges Bank purchased a new position in VCA during the fourth quarter valued at $44,158,000. Goldman Sachs Group Inc. increased its position in VCA by 64.8% in the first quarter. Goldman Sachs Group Inc. now owns 978,010 shares of the company’s stock valued at $56,421,000 after buying an additional 384,484 shares during the period. Alta Capital Management LLC purchased a new position in VCA during the second quarter valued at $16,997,000. Bogle Investment Management L P DE purchased a new position in VCA during the first quarter valued at $12,102,000. Finally, AXA increased its position in VCA by 1,179.9% in the first quarter. AXA now owns 215,203 shares of the company’s stock valued at $12,415,000 after buying an additional 198,389 shares during the period. 91.16% of the stock is currently owned by institutional investors and hedge funds.

VCA Inc. (NASDAQ:WOOF) traded down 0.32% during mid-day trading on Tuesday, hitting $69.26. 577,209 shares of the company traded hands. The company has a market capitalization of $5.60 billion, a price-to-earnings ratio of 24.71 and a beta of 1.30. VCA Inc. has a one year low of $44.00 and a one year high of $73.69. The company’s 50-day moving average price is $71.02 and its 200 day moving average price is $65.10.

VCA (NASDAQ:WOOF) last issued its quarterly earnings results on Wednesday, July 27th. The company reported $0.87 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.82 by $0.05. The business had revenue of $653.50 million for the quarter, compared to the consensus estimate of $637.18 million. VCA had a net margin of 9.93% and a return on equity of 16.86%. The firm’s quarterly revenue was up 19.1% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.70 EPS. On average, analysts anticipate that VCA Inc. will post $2.93 earnings per share for the current fiscal year.

Several research analysts have recently weighed in on WOOF shares. Jefferies Group reissued a “hold” rating on shares of VCA in a research report on Friday, August 5th. Zacks Investment Research raised shares of VCA from a “hold” rating to a “buy” rating and set a $80.00 target price on the stock in a research report on Friday, July 29th. One analyst has rated the stock with a hold rating and five have given a buy rating to the company. The company has a consensus rating of “Buy” and a consensus price target of $71.75.

In related news, Director John B. Chickering, Jr. sold 2,302 shares of the company’s stock in a transaction dated Thursday, August 4th. The shares were sold at an average price of $70.85, for a total transaction of $163,096.70. Following the transaction, the director now owns 10,992 shares in the company, valued at approximately $778,783.20. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, COO Arthur J. Antin sold 34,000 shares of the company’s stock in a transaction dated Friday, September 16th. The stock was sold at an average price of $69.03, for a total transaction of $2,347,020.00. Following the transaction, the chief operating officer now owns 89,691 shares in the company, valued at approximately $6,191,369.73. The disclosure for this sale can be found here. Corporate insiders own 4.60% of the company’s stock.

About VCA

VCA Inc is an animal healthcare company. The Company operates through five segments. Its Animal Hospital segment provides veterinary services for companion animals and sells related retail and pharmaceutical products. Its Laboratory segment provides diagnostic laboratory testing services for veterinarians, both associated with its animal hospitals and those independent of the Company.

5 Day Chart for NASDAQ:WOOF

Want to see what other hedge funds are holding WOOF? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for VCA Inc. (NASDAQ:WOOF).

Receive News & Ratings for VCA Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VCA Inc. and related companies with MarketBeat.com's FREE daily email newsletter.